Anticancer agent 232

Anticancer agent 232

• CAS Number: 9007-83-4
• UNSPSC Description: Anticancer agent 232 (compound 12f) is a glycohybrid designed using 1-azidoglycosides derived from d-glucose, d-galactose, and d-mannose. The IC50 values ​​of anticancer agent 232 against MCF-7 and MDA-MB231 cells are 1.05 μM and 18.03 μM, respectively[1].
• Target Antigen: Endogenous Metabolite
• Type: Reference compound
• Related Pathways: Metabolic Enzyme/Protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/anticancer-agent-232.html
• Smiles: O=C(C1=CC=CO1)/C=C/C2=CN(CC3=CN([C@H]4O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]4OC(C)=O)N=N3)C5=CC=C(Br)C=C52
• Molecular Weight: 727.51
• References & Citations: [1]Tyagi R,et al. Efficient synthesis of indole-chalcones based glycohybrids and their anticancer activity. Bioorg Med Chem. 2024 Jul 15;109:117778.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported